TLCD4-RWDD3

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, TLCD4-RWDD3 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated TLCD4-RWDD3 data layer compared with 28 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher TLCD4-RWDD3 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TLCD4-RWDD3 expression acts as an unfavorable survival marker.

OV are the cancer types where TLCD4-RWDD3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
OVOSMedianII,III,IV0.0100.844<.00136view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

TLCD4-RWDD3–OV (OS)

Kaplan–Meier survival curve for TLCD4-RWDD3 mutant vs wild-type samples in OV.

Open the OV breakdown →

Exploration